A million Kiwis to be impacted by major pharmaceutical company leaving New Zealand

3 July 2020 - More than a million Kiwis may need to change to different medications before the end of ...

Read more →

Companies have raised prices on 245 drugs during pandemic, advocacy group says

29 June 2020 - Pharmaceutical companies have raised prices on 245 drugs since the first U.S. coronavirus case was reported ...

Read more →

Canada federal court dismisses drug makers' plea challenging drug price rules

30 June 2020 - The federal court of Canada on Monday dismissed a plea by drug makers challenging the Canadian ...

Read more →

Solutions for the future: a new medicines landscape

30 June 2020 - Medicines New Zealand has just released the 2019/2020 edition of its annual publication New Zealand’s Medicines Landscape ...

Read more →

IMC responds to Federal Court decision regarding PMPRB regulatory changes

29 June 2020 - Innovative Medicines Canada released the following statement today in response to the Federal Court of Canada’s ...

Read more →

The reimbursement for medicines is expected to decrease by SEK 185 million in 2020

26 June 2020 - Pharmaceutical companies will pay SEK 2.9 billion in reimbursement for medicines covered by side agreements between ...

Read more →

Big pharma is taking big money from U.S. tax payers to find a coronavirus vaccine — and charge whatever they want for it

24 June 2020 - Congress must act now to ensure that COVID-19 vaccines and treatments are affordable. ...

Read more →

An ‘America first’ pharma supply chain sounds good. But it won’t work.

17 June 2020 - With a stroke of the president’s Executive Order pen, the Trump administration awarded a $354 million, ...

Read more →

Fate of pharma’s reputation lies in Gilead’s hands on pricing of COVID-19 drug remdesivir

8 June 2020 - Few remember the time when the pharmaceutical industry was the world’s most admired.  ...

Read more →

Wholesale drug prices — and net prices — keep falling for most drugs

4 June 2020 - A mid continued political pressure on the pharmaceutical industry, a new analysis finds that brand-name drug ...

Read more →

Prospective dialogue between developers and regulators makes for better evidence generation

27 May 2020 - EMA, in collaboration with other parties, has recently published two scientific articles outlining the importance of ...

Read more →

Medicines New Zealand consulting on a new generation medicines policy

26 May 2020 - The New Zealand Institute of Economic Research have produced a discussion paper for Medicines New Zealand ...

Read more →

Inside the science: companies racing to develop a COVID-19 vaccine

25 May 2020 - Even as some states move to ease the lockdowns that have cost tens of millions of ...

Read more →

Trump admin taps startup to build nation's first stockpile of key drug ingredients

19 May 2020 - The $354 million project is designed to shore up the drug supply chain and reduce the country's ...

Read more →

Top pharma official rejects idea of free COVID-19 vaccine for all

18 May 2020 - A leading representative of the pharmaceutical industry has downplayed the idea of a vaccine against the ...

Read more →